Ancient Seed Germination Sheds Light on “Archaeological Medicine” and Its Modern Relevance
Credit: Flickr/
In a remarkable discovery from the Judean Desert, researchers have identified and germinated a 1,000-year-old seed belonging to the Commiphora genus—a group of plants prized for their aromatic and medicinal resins, such as frankincense and myrrh. This seed, dated to around 993-1202 CE, represents the first confirmed example of a Commiphora species recovered and revived from an archaeological site (in this case a natural cave in Lower Wadi el-Makkuk, Judean Desert). While hypothesized to be related to the legendary “Judean Balsam” or “Balm of Gilead” mentioned in the Bible (for example Genesis 37:25), the plant exhibited unique traits that suggest a broader significance.
Chemical analysis of the plant, named “Sheba” by the research team, revealed that it did not produce the fragrant oleoresins associated with Commiphora species like C. gileadensis. Instead, it contained bioactive compounds such as pentacyclic triterpenes and a before unidentified series of glycolipids. These substances are known for their medicinal properties, including anti-inflammatory, wound-healing, and anti-tumor effects. The plant’s lack of fragrance but plenty of active compounds points to a different role for this species in ancient societies: medicinal use rather than perfumery. Such use can be seen in ancient Egypt, with the Ebers Papyrus clearly demonstrating that myrrh (from trees of the Commiphora genus) was used in wound care (for example Eb 529).
The germination of this ancient seed offers a rare opportunity to explore what might be termed “archaeological medicine”—the study of ancient plants and remedies to better understand their ethnobotanical applications. In the case of Commiphora, which has long been associated with healing in biblical texts, this discovery suggests that the medicinal properties of these plants may have been far more significant than we realized, as has been previously suggested in Talking With God pages 194-201, which lists these plants and substances along with their medical uses.
This research holds significant relevance beyond mere historical curiosity. As modern medicine confronts challenges like antibiotic resistance, chronic diseases, and the ongoing demand for novel therapeutic agents, revisiting ancient medicinal practices could provide valuable insights. The bioactive compounds found in “Sheba” have already been linked to various health benefits in other Commiphora species, underscoring the potential for ancient plants to serve as sources of new pharmaceutical compounds. Additionally, our previous research has connected many biblical-era plants to successful medicinal applications, pointing to promising directions for future investigation.
The revival of this ancient plant offers valuable insights into agricultural resilience and plant evolution, shedding light on how ancient societies cultivated certain species for both economic and medicinal purposes. This approach, often referred to as “resurrection genomics,” provides a unique opportunity to study seed longevity and environmental adaptation—knowledge that can be instrumental in crop improvement, biodiversity conservation, and even the discovery of new drugs. Additionally, it deepens our understanding of the historical relationship between these plants and their uses in biblical contexts, potentially enhancing interpretations of their significance.
In an era when modern medicine is searching for sustainable, natural sources of therapeutic agents, the study of ancient plants like Commiphora offers a promising avenue. Archaeological medicine not only enriches our understanding of historical societies but also opens the door to reviving lost knowledge with the potential to shape future medical advancements.
